ArticleBMC medical research methodology2026
Innovative statistical method for longitudinal and hierarchical data modeling: the GMEXGBoost method.
Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
objectivesOver recent decades, the exponential growth of data, especially in healthcare, has necessitated advanced analytical methods. Conventional machine learning algorithms often assume independence among data points, limiting their effectiveness with longitudinal and hierarchical data. This study introduces a novel algorithm called GMEXGBoost, a methodological extension of generalized mixed-effects models that leverages the boosting framework of XGBoost for estimating fixed effects while simultaneously accounting for random effects. The innovation lies in GMEXGBoost's ability to explicitly incorporate data correlations while retaining the predictive power of boosted trees.
methodsThe GMEXGBoost model was evaluated through extensive simulations and a real-world cohort study, benchmarking against GLMM, GLMMTree, GMERF, and XGBoost. Also, its performance was assessed using predictive mean absolute deviation (PMAD), predictive misclassification rate (PMCR), sensitivity, specificity, accuracy, and AUC. Simulation analyses were conducted using multiple synthetic datasets, each comprising training and testing groups with varying effect structures, including random intercepts and slopes. All computations were performed in RStudio(version 2023.06.0).
resultsOur results indicate that while XGBoost achieved the lowest average errors across most scenarios, GMEXGBoost consistently demonstrated superior stability and accuracy when random-effect variance was large or correlations were strong. Also, in real data, GMEXGBoost outperformed other models in terms of the performance metrics.
conclusionThe GMEXGBoost algorithm, by combining the estimates of the GLMM and XGBoost models, leverages the capabilities of both and delivers improved performance in complex problems. Although it is not universally superior, but demonstrates clear advantages in the analysis of hierarchical and longitudinal datasets with strong correlations. These properties make it a valuable tool for decision-making in healthcare and other domains that involve complex, structured data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.